 | • レポートコード：MRC2312MG09957 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のテルリプレシン注射液市場規模と予測を収録しています。・世界のテルリプレシン注射液市場：売上、2018年-2023年、2024年-2029年 ・世界のテルリプレシン注射液市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のテルリプレシン注射液市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「先発医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 テルリプレシン注射液のグローバル主要企業は、Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodtなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、テルリプレシン注射液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のテルリプレシン注射液市場：タイプ別、2018年-2023年、2024年-2029年 世界のテルリプレシン注射液市場：タイプ別市場シェア、2022年 ・先発医薬品、ジェネリック医薬品 世界のテルリプレシン注射液市場：用途別、2018年-2023年、2024年-2029年 世界のテルリプレシン注射液市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界のテルリプレシン注射液市場：地域・国別、2018年-2023年、2024年-2029年 世界のテルリプレシン注射液市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるテルリプレシン注射液のグローバル売上、2018年-2023年 ・主要企業におけるテルリプレシン注射液のグローバル売上シェア、2022年 ・主要企業におけるテルリプレシン注射液のグローバル販売量、2018年-2023年 ・主要企業におけるテルリプレシン注射液のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodt ************************************************************* ・調査・分析レポートの概要 テルリプレシン注射液市場の定義 市場セグメント 世界のテルリプレシン注射液市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のテルリプレシン注射液市場規模 世界のテルリプレシン注射液市場規模：2022年 VS 2029年 世界のテルリプレシン注射液市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのテルリプレシン注射液の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のテルリプレシン注射液製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：先発医薬品、ジェネリック医薬品 テルリプレシン注射液のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 テルリプレシン注射液の用途別グローバル売上・予測 ・地域別市場分析 地域別テルリプレシン注射液市場規模 2022年と2029年 地域別テルリプレシン注射液売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Hubei JX Bio Pharmaceutical Co., Ltd.、 Hainan Poly Pharm Co., Ltd.、 Hybio Pharmaceutical Co., Ltd.、 Ferring Pharmaceuticals Co., Ltd.、 Chinese Peptide Co., Ltd.、 EVER Pharma、 Wellona Pharma、 Trumac Healthcare、 Mallinckrodt ... |
This research report provides a comprehensive analysis of the Terlipressin Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Terlipressin Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Terlipressin Injection, challenges faced by the industry, and potential opportunities for market players.
The global Terlipressin Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Terlipressin Injection market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Terlipressin Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Terlipressin Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Terlipressin Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Terlipressin Injection market.
Market Overview: The report provides a comprehensive overview of the Terlipressin Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Original Drugs, Generic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Terlipressin Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Terlipressin Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Terlipressin Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Terlipressin Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Terlipressin Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Terlipressin Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Terlipressin Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Terlipressin Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Terlipressin Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drugs
Generic Drugs
Market segment by Application
Hospital
Clinic
Other
Global Terlipressin Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hubei JX Bio Pharmaceutical Co., Ltd.
Hainan Poly Pharm Co., Ltd.
Hybio Pharmaceutical Co., Ltd.
Ferring Pharmaceuticals Co., Ltd.
Chinese Peptide Co., Ltd.
EVER Pharma
Wellona Pharma
Trumac Healthcare
Mallinckrodt
Outline of Major Chapters:
Chapter 1: Introduces the definition of Terlipressin Injection, market overview.
Chapter 2: Global Terlipressin Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Terlipressin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Terlipressin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Terlipressin Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Terlipressin Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Terlipressin Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Terlipressin Injection Overall Market Size
2.1 Global Terlipressin Injection Market Size: 2022 VS 2029
2.2 Global Terlipressin Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Terlipressin Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Terlipressin Injection Players in Global Market
3.2 Top Global Terlipressin Injection Companies Ranked by Revenue
3.3 Global Terlipressin Injection Revenue by Companies
3.4 Global Terlipressin Injection Sales by Companies
3.5 Global Terlipressin Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Terlipressin Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Terlipressin Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Terlipressin Injection Players in Global Market
3.8.1 List of Global Tier 1 Terlipressin Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Terlipressin Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Terlipressin Injection Market Size Markets, 2022 & 2029
4.1.2 Original Drugs
4.1.3 Generic Drugs
4.2 By Type – Global Terlipressin Injection Revenue & Forecasts
4.2.1 By Type – Global Terlipressin Injection Revenue, 2018-2023
4.2.2 By Type – Global Terlipressin Injection Revenue, 2024-2029
4.2.3 By Type – Global Terlipressin Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Terlipressin Injection Sales & Forecasts
4.3.1 By Type – Global Terlipressin Injection Sales, 2018-2023
4.3.2 By Type – Global Terlipressin Injection Sales, 2024-2029
4.3.3 By Type – Global Terlipressin Injection Sales Market Share, 2018-2029
4.4 By Type – Global Terlipressin Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Terlipressin Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Terlipressin Injection Revenue & Forecasts
5.2.1 By Application – Global Terlipressin Injection Revenue, 2018-2023
5.2.2 By Application – Global Terlipressin Injection Revenue, 2024-2029
5.2.3 By Application – Global Terlipressin Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Terlipressin Injection Sales & Forecasts
5.3.1 By Application – Global Terlipressin Injection Sales, 2018-2023
5.3.2 By Application – Global Terlipressin Injection Sales, 2024-2029
5.3.3 By Application – Global Terlipressin Injection Sales Market Share, 2018-2029
5.4 By Application – Global Terlipressin Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Terlipressin Injection Market Size, 2022 & 2029
6.2 By Region – Global Terlipressin Injection Revenue & Forecasts
6.2.1 By Region – Global Terlipressin Injection Revenue, 2018-2023
6.2.2 By Region – Global Terlipressin Injection Revenue, 2024-2029
6.2.3 By Region – Global Terlipressin Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Terlipressin Injection Sales & Forecasts
6.3.1 By Region – Global Terlipressin Injection Sales, 2018-2023
6.3.2 By Region – Global Terlipressin Injection Sales, 2024-2029
6.3.3 By Region – Global Terlipressin Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Terlipressin Injection Revenue, 2018-2029
6.4.2 By Country – North America Terlipressin Injection Sales, 2018-2029
6.4.3 US Terlipressin Injection Market Size, 2018-2029
6.4.4 Canada Terlipressin Injection Market Size, 2018-2029
6.4.5 Mexico Terlipressin Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Terlipressin Injection Revenue, 2018-2029
6.5.2 By Country – Europe Terlipressin Injection Sales, 2018-2029
6.5.3 Germany Terlipressin Injection Market Size, 2018-2029
6.5.4 France Terlipressin Injection Market Size, 2018-2029
6.5.5 U.K. Terlipressin Injection Market Size, 2018-2029
6.5.6 Italy Terlipressin Injection Market Size, 2018-2029
6.5.7 Russia Terlipressin Injection Market Size, 2018-2029
6.5.8 Nordic Countries Terlipressin Injection Market Size, 2018-2029
6.5.9 Benelux Terlipressin Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Terlipressin Injection Revenue, 2018-2029
6.6.2 By Region – Asia Terlipressin Injection Sales, 2018-2029
6.6.3 China Terlipressin Injection Market Size, 2018-2029
6.6.4 Japan Terlipressin Injection Market Size, 2018-2029
6.6.5 South Korea Terlipressin Injection Market Size, 2018-2029
6.6.6 Southeast Asia Terlipressin Injection Market Size, 2018-2029
6.6.7 India Terlipressin Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Terlipressin Injection Revenue, 2018-2029
6.7.2 By Country – South America Terlipressin Injection Sales, 2018-2029
6.7.3 Brazil Terlipressin Injection Market Size, 2018-2029
6.7.4 Argentina Terlipressin Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Terlipressin Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Terlipressin Injection Sales, 2018-2029
6.8.3 Turkey Terlipressin Injection Market Size, 2018-2029
6.8.4 Israel Terlipressin Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Terlipressin Injection Market Size, 2018-2029
6.8.6 UAE Terlipressin Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hubei JX Bio Pharmaceutical Co., Ltd.
7.1.1 Hubei JX Bio Pharmaceutical Co., Ltd. Company Summary
7.1.2 Hubei JX Bio Pharmaceutical Co., Ltd. Business Overview
7.1.3 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Major Product Offerings
7.1.4 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.1.5 Hubei JX Bio Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Hainan Poly Pharm Co., Ltd.
7.2.1 Hainan Poly Pharm Co., Ltd. Company Summary
7.2.2 Hainan Poly Pharm Co., Ltd. Business Overview
7.2.3 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Major Product Offerings
7.2.4 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.2.5 Hainan Poly Pharm Co., Ltd. Key News & Latest Developments
7.3 Hybio Pharmaceutical Co., Ltd.
7.3.1 Hybio Pharmaceutical Co., Ltd. Company Summary
7.3.2 Hybio Pharmaceutical Co., Ltd. Business Overview
7.3.3 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Major Product Offerings
7.3.4 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.3.5 Hybio Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Ferring Pharmaceuticals Co., Ltd.
7.4.1 Ferring Pharmaceuticals Co., Ltd. Company Summary
7.4.2 Ferring Pharmaceuticals Co., Ltd. Business Overview
7.4.3 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Major Product Offerings
7.4.4 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.4.5 Ferring Pharmaceuticals Co., Ltd. Key News & Latest Developments
7.5 Chinese Peptide Co., Ltd.
7.5.1 Chinese Peptide Co., Ltd. Company Summary
7.5.2 Chinese Peptide Co., Ltd. Business Overview
7.5.3 Chinese Peptide Co., Ltd. Terlipressin Injection Major Product Offerings
7.5.4 Chinese Peptide Co., Ltd. Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.5.5 Chinese Peptide Co., Ltd. Key News & Latest Developments
7.6 EVER Pharma
7.6.1 EVER Pharma Company Summary
7.6.2 EVER Pharma Business Overview
7.6.3 EVER Pharma Terlipressin Injection Major Product Offerings
7.6.4 EVER Pharma Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.6.5 EVER Pharma Key News & Latest Developments
7.7 Wellona Pharma
7.7.1 Wellona Pharma Company Summary
7.7.2 Wellona Pharma Business Overview
7.7.3 Wellona Pharma Terlipressin Injection Major Product Offerings
7.7.4 Wellona Pharma Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.7.5 Wellona Pharma Key News & Latest Developments
7.8 Trumac Healthcare
7.8.1 Trumac Healthcare Company Summary
7.8.2 Trumac Healthcare Business Overview
7.8.3 Trumac Healthcare Terlipressin Injection Major Product Offerings
7.8.4 Trumac Healthcare Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.8.5 Trumac Healthcare Key News & Latest Developments
7.9 Mallinckrodt
7.9.1 Mallinckrodt Company Summary
7.9.2 Mallinckrodt Business Overview
7.9.3 Mallinckrodt Terlipressin Injection Major Product Offerings
7.9.4 Mallinckrodt Terlipressin Injection Sales and Revenue in Global (2018-2023)
7.9.5 Mallinckrodt Key News & Latest Developments
8 Global Terlipressin Injection Production Capacity, Analysis
8.1 Global Terlipressin Injection Production Capacity, 2018-2029
8.2 Terlipressin Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Terlipressin Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Terlipressin Injection Supply Chain Analysis
10.1 Terlipressin Injection Industry Value Chain
10.2 Terlipressin Injection Upstream Market
10.3 Terlipressin Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Terlipressin Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
